Good heart health during early pregnancy may reduce genetic risk of preeclampsia and hypertension

Maintaining good cardiovascular health during the first trimester of pregnancy may offset the genetic risk of developing preeclampsia and/or gestational hypertension, according to preliminary research presented at the American Heart Association’s Hypertension Scientific Sessions 2024.

World’s first CRISPR-based gene therapy approved for sickle cell anaemia – Pharmaceutical Technology

Share this article Casgevy has been approved for treating sickle cell disease and transfusion-dependent beta thalassemia patients aged 12 and older in the UK. Image

November 16, 2023

Nearly half of cancer drugs granted accelerated approval didn’t end up showing clinical benefit — study

Almost half of cancer drugs that received accelerated approval didn’t end up improving quality of life or survival after five years of follow-up, Harvard University

April 9, 2024

Opinion | A Framework to Communicate With Pregnant Patients About the RSV Vaccine

Gorman is a public health and behavioral science expert. Scales is a professor of medicine. Cartwright is an ob/gyn. Respiratory syncytial virus (RSV) is a

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.